Vaccine Allocation Decision on the allocation of COVAX Facility secured vaccines: 11 April 2022

Overview

COVAX Allocation Round 15 (R15) is the first allocation round of Phase 2 and allocates available vaccine supply to participants for a six month period, namely from April to September 2022 (inclusive).  As per COVAX Phase 2 principles and objectives, R15 focuses on meeting the demand expressed by AMC (Advance Market Commitment) participants in line with their national targets. Similarly to Round 14, and as per Phase 2 principles, APA (Advance Purchase Agreement) doses and donated doses are allocated together in R15.


 

 

WHO Team
COVAX, Independent Allocation of Vaccines Group
Number of pages
19